Management of migraine using acupuncture in a double-blind study
Baust, W.; Stürtzbecher, K.H.
Die Medizinische Welt 29(16): 669-673
1978
ISSN/ISBN: 0025-8512 PMID: 347221 Document Number: 129740
Document emailed within 1 workday
Related Documents
Grotemeyer, K.H.; Schlake, H.P.; Husstedt, I.W. 1988: Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study Der Nervenarzt 59(9): 549-552Langohr, H.D.; Reinecke, M.; Gerber, W.D.; Mangold, R. 1988: Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study Fortschritte der Medizin 106(2): 65
Pothmann, R. 1987: Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(9): 646-649
Wörz, R.; Reinhardt-Benmalek, B.; Föh, M.; Grotemeyer, K.H.; Scharafinski, H.W. 1992: Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol Fortschritte der Medizin 110(14): 268-272
Di Trapani, G.; Mei, D.; Marra, C.; Mazza, S.; Capuano, A. 2000: Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study La Clinica Terapeutica 151(3): 145-148
Duplan, B.; Cabanel, G.; Piton, J.L.; Grauer, J.L.; Phelip, X. 1983: Acupuncture and sciatica in the acute phase. Double-blind study of 30 cases La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(45): 3109-3114
Gerber, W.D.; Schellenberg, R.; Thom, M.; Haufe, C.; Bölsche, F.; Wedekind, W.; Niederberger, U.; Soyka, D. 1995: Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study Functional Neurology 10(1): 27-35
Rompel, H.; Bauermeister, P.W. 1970: Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study South African Medical Journal 44(4): 75-80
Lynggaard, F.; Ostergaard, F. 1975: Clonidine in prevention of migraine. Report of a double-blind study of 38 patients referred for neurological assessment Ugeskrift for Laeger 137(3): 149-151
Russell, M.B.; Holm-Thomsen, O.E.; Nielsen, M.R.; Cleal, A.; Pilgrim, A.J.; Olesen, J. 1995: Sumatriptan treatment of migraine in general practice. a randomized, double-blind, placebo-controlled cross-over study Ugeskrift for Laeger 157(16): 2320-2323
Sulman, F.G.; Pfeifer, Y.; Superstine, E. 1981: Preventive treatment of serotonin-migraine with 1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino-(1,2--d)-(1,4)-oxazepine hydrogen maleate (Org GC 94). A double-blind study Arzneimittel-Forschung 31(1): 109-112
Salonen, R.; Ashford, E.A.; Gibbs, M.; Hassani, H. 1999: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group International Journal of Clinical Practice. Supplement 105: 16-24
Savani, N.; Brautaset, N.J.; Reunanen, M.; Szirmai, I.; Ashford, E.A.; Hassani, H.; Saiers, J. 1999: A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group International Journal of Clinical Practice. Suppl 105: 7-15
Arthur, G.P.; Hornabrook, R.W. 1971: The treatment of migraine with BC 105 (pizotifen): a double blind trial New Zealand Medical Journal 73(464): 5-9
Arthur, G.P.; Hornabrook, R.W. 1971: The treatment of migraine with BC 105 (pizotifen): a double blind trial New Zealand Medical Journal 73(464): 5-9
Vo, A.H.; Satori, R.; Jabbari, B.; Green, J.; Killgore, W.D.S.; Labutta, R.; Campbell, W.W. 2007: Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial Aviation Space and Environmental Medicine 78(5 Suppl): B113-B118
Frenken, C.W.; Nuijten, S.T. 1984: Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo Fortschritte der Medizin 102(12): 349-351
Yuill, G.M.; Swinburn, W.R.; Liversedge, L.A. 1972: A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine British Journal of Clinical Practice 26(2): 76-79
Lacey, P.H.; Dodd, G.D.; Shannon, D.J. 1984: A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders European Journal of Rheumatology and Inflammation 7(3): 95-104
Shrestha, M.; Singh, R.; Moreden, J.; Hayes, J.E. 1996: Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial Archives of Internal Medicine 156(15): 1725-1728